Literature DB >> 6587382

Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells.

Y Yuasa, R A Gol, A Chang, I M Chiu, E P Reddy, S R Tronick, S A Aaronson.   

Abstract

An N-ras-related transforming gene was detected in the human lung carcinoma cell line SW-1271 and molecularly cloned. The lesion responsible for its acquisition of transforming activity was localized to a single nucleotide transition from A to G in codon 61 of the predicted protein. This lesion in the second exon results in the substitution of arginine for glutamine at this position. These findings, together with previous studies, indicate that the activation of ras oncogenes in human tumors is most commonly due to point mutations at one of two major "hot spots" in the ras coding sequence.

Entities:  

Mesh:

Year:  1984        PMID: 6587382      PMCID: PMC345280          DOI: 10.1073/pnas.81.12.3670

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line.

Authors:  K Shimizu; M Goldfarb; M Perucho; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations.

Authors:  D J Capon; P H Seeburg; J P McGrath; J S Hayflick; U Edman; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

3.  Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1.

Authors:  A Hall; C J Marshall; N K Spurr; R A Weiss
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

4.  The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors.

Authors:  M J Murray; J M Cunningham; L F Parada; F Dautry; P Lebowitz; R A Weinberg
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

7.  Oncogenes in solid human tumours.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; S A Aaronson; M Barbacid
Journal:  Nature       Date:  1982-12-09       Impact factor: 49.962

8.  Three human transforming genes are related to the viral ras oncogenes.

Authors:  K Shimizu; M Goldfarb; Y Suard; M Perucho; Y Li; T Kamata; J Feramisco; E Stavnezer; J Fogh; M H Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.

Authors:  A P Feinberg; B Vogelstein; M J Droller; S B Baylin; B D Nelkin
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

10.  Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.

Authors:  K Shimizu; D Birnbaum; M A Ruley; O Fasano; Y Suard; L Edlund; E Taparowsky; M Goldfarb; M Wigler
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

View more
  25 in total

Review 1.  From genes to drugs: targeted strategies for melanoma.

Authors:  Keith T Flaherty; F Stephen Hodi; David E Fisher
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

2.  Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein.

Authors:  J C Lacal; S A Aaronson
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

3.  Monoclonal antibody specific for an activated RAS protein.

Authors:  W P Carney; D Petit; P Hamer; C J Der; T Finkel; G M Cooper; M Lefebvre; H Mobtaker; R Delellis; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene.

Authors:  E P Reddy; D Lipman; P R Andersen; S R Tronick; S A Aaronson
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Cell type-specific expressions of c-ras gene products in the normal rat.

Authors:  T Tanaka; N Ida; C Waki; H Shimoda; D J Slamon; M J Cline
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

6.  Effects of fructose on human fibroblast metabolism: the application of DNA measurements as a basis for interpretation.

Authors:  R Z Eanes
Journal:  In Vitro Cell Dev Biol       Date:  1985-06

7.  Organ specific expression of ras oncoproteins during growth and development of the rat.

Authors:  T Tanaka; N Ida; H Shimoda; C Waki; D J Slamon; M J Cline
Journal:  Mol Cell Biochem       Date:  1986-04       Impact factor: 3.396

8.  A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.

Authors:  M H Kraus; Y Yuasa; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Inference of cancer-specific gene regulatory networks using soft computing rules.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  Gene Regul Syst Bio       Date:  2010-03-24

10.  Alteration of glycolipids in ras-transfected NIH 3T3 cells.

Authors:  G R Matyas; S A Aaronson; R O Brady; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.